FIIs go back to India after 12 months of absence, says HSBC; Chooses 11 shares

Only one day after HSBC has upgraded Indian shares to ‘overweight’ of ‘neutral’ after attractive valuations, supporting government policy and resilient domestic streams, the broker has now said that foreign institutional investors (FIIs) will probably make a comeback after a long -term absence of 12 months.

To take advantage of this trend, HSBC has mentioned 11 shares as his top choices – Marico, Trent, Mahindra & Mahindra, Phoenix Mills, HDFC Bank, Icici Lombard, Ultratech Cement, Infosys, Adani Ports and SEZ, Divi’s Laboratories and NTPC.

HSBC attracted a cricket analogy and said that Indian shares will return to form, driven by attractive valuations, lower inflation and reducing monetary policy. “We think that the income is almost at the bottom and are set to improve,” said the brokerage in a note of 26 September.

Also read: Watch out! RS 2,000 crore of shares to enter the market in the next 3 months. Check key names

On the prospect of the influx of FII, HSBC pointed out that external positioning is now heavy crooked to markets such as Korea and Taiwan, where streams were financed by selling Indian shares, making them busy. At the same time, a mitigating dollar and potential tariff reductions from the American Federal Reserve can cause a rotation in emerging markets – a shift that still has to be done, but a shift that benefits India. “Although American rates have a limited impact on income, positive trade developments can activate movements of investors on the sidelines,” the memorandum added.

It is expected that recent demand measures on the demand side will increase consumption, so that the analysts of HSBC increase their growth reasons. Car sales will benefit, while consumer staples could see margin repair next year. In the financial data, the exhibition is preferred to large banks, diversified financial data and multi-line non-living insurers, in the expectation of the margins of lenders in 2026. The prospects for technology services have been brightened after a considerable revaluation, where the demand will probably collect next year. While American rates remain an overhang for medicines, HSBC believes that the risk is limited in view of the dependence on America of Indian generic medicines. Dearlier this week described India brokers as a “quiet corner” as a “quiet corner” in the midst of asian markets such as Korea and Taiwan, which described the relative weather of the country of policy support and stable macro -economic foundations. India’s profession, it said, lies in a combination of normalized valuations, light foreign positioning and a government focused on reforms and capex-guided growth. Although the profit expectations can relieve, it does not see that if a high risk is seen as a strong confidence of investors and the constant policy momentum.

Read more: Hyundai shares collect nearly 90% from the April low. Can it become a multibagger? Benchmark Indices Nifty and Sensex witnessed a huge sale in today’s session after the US President Donald Trump had announced a steep 100% rates for roasted and patented drugs from 1 October. The 30-stock index ended at 80.426.46, Down 733.22 or 0.90% while the wider Nify Settle at 24,654.70, 236.50%.

(Disclaimer: recommendations, suggestions, views and opinions of the experts are their own. These do not represent the views of economic times)